Brian De, M.D.

Peer-Reviewed Articles

1. Carriere, P, Haisraely, O, Aaroe, AE, Ahmed, K, Lewis, R, Colson-Fearon, D, Bolden, M, Swanson, T, Beckham, TH, Wang, C, De, BS, Perni, S, Tom, MC, Li, J, McGovern, SL, McAleer, MF, Ghia, AJ, Jiang, W, Chung, C, Grosshans, DR, Ballester, L, Esquenazi, Y, Kamiya Matsuoka, C, Yeboa, DN. Long-term outcomes in IDH-wildtype (IDH-wt) gliomas with historical WHO grade 2 and 3 histology. Journal of neuro-oncology 179(1), 2026. e-Pub 2026. PMID: 42489814.
2. Abi Jaoude, J, Lau, A, Yuan, Y, Meimoun, NS, De, BS, Liao, K, Kouzy, R, Nieves-Jimenez, HR, Poenisch, F, Balter, PA, Brock, K, Sawakuchi, GO, Vauthey, JN, Tzeng, CD, Shamsutdinova, D, Lazar, A, Chatterjee, D, Holliday, EB, Smith, GL, Minsky, B, Das, P, Koong, A, Lee, SS, Tran Cao, HS, Javle, M, Kwong, L, Koay, EJ, Ludmir, EB. Clinicogenomic and Histopathologic Analyses of Supermassive Intrahepatic Cholangiocarcinoma and the Role of Ablative Radiotherapy. Clinical Cancer Research 32(10):2079-2087, 2026. e-Pub 2026. PMID: 41923341.
3. Beckham, TH, Dudzinski, SO, Rooney, M, Faraj, CA, Pasli, M, Perni, S, Tom, MC, Ghia, AJ, Yeboa, DN, McAleer, MF, Swanson, T, McGovern, SL, Wang, C, Chung, C, De, BS, Jiang, W, Kim, BY, Ferguson, SD, Tawbi, H, Glitza, I, Le, X, Kaya, D, Dumbrava, EE, Briere, TM, Mackin, DS, Li, J. Incorporating an NCCN-Based Systemic Therapy CNS Activity Score Into SRS Decision-Making for Patients With 5 or More Brain Metastases. JNCCN Journal of the National Comprehensive Cancer Network 24(2):34-40, 2026. e-Pub 2026. PMID: 41671425.
4. Yeboa, DN, Whitfield, BT, Lin, R, Ejezie, CL, Swanson, T, Beckham, TH, Wang, C, De, BS, Perni, S, Tom, MC, Li, J, McGovern, SL, Harrison, R, Majd, NK, Puduvalli, VK, Aaroe, AE, Loghin, ME, O'Brien, BJ, Patel, AD, Patel, C, Wefel, JS, Taslicay, CA, Gule-Monroe, MK, Paulino, AC, McAleer, MF, Grosshans, DR, Ghia, AJ, Jiang, W, Chung, C, Maor, MM, Yang, CH, Gubbiotti, M, Kamiya Matsuoka, C, Ballester, L, Weathers, S, Huse, J. Prospective phase II clinical trial of molecular glioblastoma (historical grade 2 and 3 IDH wildtype gliomas) preliminary novel exploratory analyses. Journal of neuro-oncology 176(1), 2026. e-Pub 2026. PMID: 41191157.
5. De, BS, Dogra, P, Zaid, M, Elganainy, D, Sun, K, Amer, A, Wang, CX, Rooney, M, Chang, E, Kang, H, Wang, Z, Bhosale, PR, Odisio, BC, Newhook, TE, Tzeng, CD, Tran Cao, HS, Chun, YS, Vauthey, JN, Lee, SS, Kaseb, A, Raghav, KS, Javle, M, Minsky, B, Noticewala, SS, Holliday, EB, Smith, GL, Koong, AC, Das, P, Cristini, V, Ludmir, EB, Koay, EJ. Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response. npj Systems Biology and Applications 11(1), 2025. e-Pub 2025. PMID: 41387975.
6. Thonglert K, Apisarnthanarax S, Yeap BY, Havard ME, Schaub SK, Nyflot MJ, Bowen SR, He Y, Tsai J, De BS, Chamseddine I, Pursley J, Roberts H, Wo J, Prayongrat A, Alisanant P, Amornwichet N, Khorprasert C, Hong T, Koay EJ, Grassberger C. Establishing Albumin-Bilirubin Score Changes as Predictors of Radiation-Induced Liver Disease in Hepatocellular Carcinoma Patients Post-External Beam Radiation Therapy. Int J Radiat Oncol Biol Phys 125(2):481-488, 2025. e-Pub 2025. PMID: 41248759.
7. Haisraely O, Vedala S, Al-Sharfeen A, Manzar GS, Perni S, Tom MC, Beckham TH, Wang C, Yeboa DN, Chung C, McAleer MF, Ghia AJ, Ene CI, Weathers SP, McGovern SL, Wogan CF, Roth M, Li J, De B. Glioblastoma in young adult patients: contemporary patterns of care and survival in the United States. J Neurooncol 175(1):323-331, 2025. e-Pub 2025. PMID: 40663309.
8. Andrade-Almeida, RA, Call-Orellana, F, Zuluaga-Garcia, JP, Ramirez-Ferrer, E, Kimchi, G, De, BS, Guimaraes, AB, Alvarez-Breckenridge, C, Li, J, Ghia, AJ, Rhines, LD, Tom, MC, Wang, C, Beckham, TH, Amini, B, North, RY, Tatsui, CE. Local Control After Adjuvant Radiosurgery for Spinal Metastasis Treated With Decompression and Posterior Segmental Stabilization. Advances in Radiation Oncology 10(7), 2025. e-Pub 2025. PMID: 40548160.
9. Yeboa DN, Li J, Lin R, Prabhu SS, Beckham TH, Woodhouse K, Swanson TA, Weinberg JS, Wang X, Chi X, Ejezie CL, Suki D, Wang C, Ene C, McCutcheon IE, McGovern S, McAleer MF, Tom M, Ghia A, Perni S, Jiang W, De B, Chung C, Kim BYS, O'Brien BJ, Huse JT, Wefel JS, Court L, Tawbi H, Janku F, Guha-Thakurta N, Debnam JM, Johnson J, Taslicay CA, Alvarez-Breckenridge C, Raza SM, Heimberger AB, DeMonte F, North R, Briere TM, de Groot JF, Sawaya R, Grosshans D, Lang FF, Rao G, Ferguson SD. Therapy, Safety, and Logistics of Preoperative vs Postoperative Stereotactic Radiation Therapy: A Preliminary Analysis of a Randomized Clinical Trial. JAMA Oncol 11(8):890-899, 2025. e-Pub 2025. PMID: 40531511.
10. Alizada S, Eldaya RW, Salim HA, Taslicay CA, Gubbiotti MA, De B, Weathers SP, Wintermark M, Al Qudah H. Clinical and Imaging Features of Primary Intradural Extramedullary Ewing Sarcoma. AJNR Am J Neuroradiol 46(12):2697-2704, 2025. e-Pub 2025. PMID: 40506234.
11. Corrigan KL, Berkman AM, Gunther J, Andersen CR, Wu S, Gibson A, Cuglievan B, Garcia MB, Manzar G, Fang P, De B, Ahmed S, Nunez C, Hildebrandt MAT, McCall DC, Parsons SK, Roth ME. Trends in Radiation Use from 2004-2020 Among Adolescents and Young Adults with Hodgkin Lymphoma. Cancer Epidemiol Biomarkers Prev 34(9):1483-1491, 2025. e-Pub 2025. PMID: 40488452.
12. Salazar RM, Nair SS, Leone AO, Xu T, Mumme RP, Duryea JD, De B, Corrigan KL, Rooney MK, Ning MS, Das P, Holliday EB, Liao Z, Court LE, Niedzielski JS. Performance Comparison of 10 State-of-the-Art Machine Learning Algorithms for Outcome Prediction Modeling of Radiation-Induced Toxicity. Adv Radiat Oncol 10(2):101675, 2025. e-Pub 2025. PMID: 39717195.
13. Florez MA, De B, Kowalchuk R, Tang C, Bishop AJ, Kouzy R, Amini B, Briere T, Beckham TH, Wang C, Li J, Tatsui CE, Rhines LD, Brown PD, Merrell K, Ghia AJ. Validation of the prognostic index for spine metastasis (PRISM) for stratifying survival in patients treated with spinal stereotactic body radiation. Radiother Oncol 201:110570, 2024. e-Pub 2024. PMID: 39362605.
14. Tom MC, Komatineni S, Wang C, de Almeida RAA, Ghia AJ, Beckham TH, Perni S, McAleer MF, Swanson T, Yeboa DN, De BS, Rooney MK, Bishop AJ, Reddy JP, Yang Y, Ludmir EB, Zhang S, Amini B, Alvarez-Breckenridge C, North RY, Rhines LD, Li J, Tatsui CE. Spinal laser interstitial thermal therapy and radiotherapy for thoracic metastatic epidural spinal cord compression. J Neurooncol 170(2):289-296, 2024. e-Pub 2024. PMID: 39325339.
15. De B, Dogra P, Zaid M, Elganainy D, Sun K, Amer AM, Wang C, Rooney MK, Chang E, Kang HC, Wang Z, Bhosale P, Odisio BC, Newhook TE, Tzeng CD, Cao HST, Chun YS, Vauthey JN, Lee SS, Kaseb A, Raghav K, Javle M, Minsky BD, Noticewala SS, Holliday EB, Smith GL, Koong AC, Das P, Cristini V, Ludmir EB, Koay EJ. Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response. medRxiv, 2024. e-Pub 2024. PMID: 39314943.
16. Beckham TH, Rooney MK, Cifter G, Bernard V, McAleer MF, De BS, Tom MC, Perni S, Wang C, Swanson T, Tatsui CE, Alvarez-Breckenridge C, North R, Rhines LD, Tang C, Logothetis C, Amini B, Li J, Yeboa DN, Ghia AJ. Stereotactic radiosurgery for prostate cancer spine metastases: local control and fracture risk using a simultaneous integrated boost approach. J Neurosurg Spine 41(3):436-444, 2024. e-Pub 2024. PMID: 38875722.
17. Beckham, TH, Dudzinski, SO, Pasli, M, Perni, S, Tom, MC, Ghia, AJ, Yeboa, DN, McAleer, MF, Swanson, T, McGovern, SL, Wang, C, Chung, C, Briere, TM, An, R, De, BS, Glitza, IC, Kim, YB, McCutcheon, IE, Ferguson, SD, Li, J. Radiosurgery to 5 or more newly diagnosed brain metastases in the systemic therapy era. Journal of Clinical Oncology 42(16):2026, 2024. e-Pub 2024.
18. Wang, C, Rooney, MK, Alvarez-Breckenridge, C, Beckham, TH, Chung, C, De, BS, Ghia, AJ, Grosshans, DR, Majd, NK, McAleer, MF, McGovern, SL, North, RY, Paulino, AC, Perni, S, Reddy, JP, Rhines, LD, Swanson, T, Tatsui, CE, Tom, MC, Yeboa, DN, Li, J. Outcomes and Pattern of Care for Spinal Myxopapillary Ependymoma in the Modern Era—A Population-Based Observational Study. Cancers 16(11), 2024. e-Pub 2024. PMID: 38893133.
19. Shi C, De B, Tran Cao HS, Liu S, Florez MA, Kouzy R, Grippin AJ, Katz MHG, Tzeng CD, Ikoma N, Kim MP, Lee S, Willis J, Noticewala SS, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Ludmir EB, Koay EJ. Escalated-dose radiotherapy for unresected locally advanced pancreatic cancer: Patterns of care and survival in the United States. Cancer Medicine 13(12):E7434, 2024. e-Pub 2024. PMID: 38923407.
20. Beckham TH, Rooney MK, McAleer MF, Ghia AJ, Tom MC, Perni S, McGovern S, Grosshans D, Chung C, Wang C, De B, Swanson T, Paulino A, Jiang W, Ferguson S, Patel CB, Li J, Yeboa DN. Hypofractionated radiotherapy for glioblastoma: A large institutional retrospective assessment of 2 approaches. Neuro-oncol Practice 11(3):266-274, 2024. e-Pub 2024. PMID: 38737610.
21. Wang C, Rooney MK, Alvarez-Breckenridge C, Beckham TH, Chung C, De BS, Ghia AJ, Grosshans D, Majd NK, McAleer MF, McGovern SL, North RY, Paulino AC, Perni S, Reddy JP, Rhines LD, Swanson TA, Tatsui CE, Tom MC, Yeboa DN, Li J. Outcomes and Pattern of Care for Spinal Myxopapillary Ependymoma in the Modern Era-A Population-Based Observational Study. Cancers (Basel) 16(11), 2024. e-Pub 2024. PMID: 38893133.
22. Salazar RM, Duryea JD, Leone AO, Nair SS, Mumme RP, De B, Corrigan KL, Rooney MK, Das P, Holliday EB, Court LE, Niedzielski JS. Random forest modeling of acute toxicity in anal cancer: Effects of peritoneal cavity contouring approaches on model performance. Int J Radiat Oncol Biol Phys 118(2):554-564, 2024. e-Pub 2023. PMID: 37619789.
23. Jan I, De B, Kwon YS, Freeman R, Larkin K, Subramanian S, Prathyusha P, Song A, Young M, Sayan M, Beier M, Ludmir EB, Haffty BG, Mattes M. Race and Sex-Based Variation in Industry Research and General Payments to Medical Oncologists in the United States. JCO. e-Pub 2024.
24. Sherry AD, Maroongroge S, De B, Amini B, Conley AP, Bishop AJ, Wang C, Beckham T, Tom M, Briere T, Li J, Yeboa DN, McAleer MF, North R, Tatsui CE, Rhines LD, Ghia AJ. Management of chordoma and chondrosarcoma with definitive dose-escalated single-fraction spine stereotactic radiosurgery. J Neurooncol 164(2):377-386, 2023. e-Pub 2023. PMID: 37667065.
25. De B, Upadhyay R, Liao K, Kumala T, Shi C, Dodoo G, Abi Jaoude J, Corrigan KL, Manzar GS, Marqueen KE, Bernard V, Lee SS, Raghav KPS, Vauthey JN, Tzeng CD, Tran Cao HS, Lee G, Wo JY, Hong TS, Crane CH, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Javle M, Ludmir EB, Koay EJ. Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases. Liver Cancer 12(3):198-208, 2023. e-Pub 2023. PMID: 37593365.
26. Chamseddine I, Kim Y, De B, Naqa IE, Duda DG, Wolfgang JA, Pursley J, Wo JY, Hong TS, Paganetti H, Koay EJ, Grassberger C. Predictive Model of Liver Toxicity to Aid the Personalized Selection of Proton Versus Photon Therapy in Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys 116(5):1234-1243, 2023. e-Pub 2023. PMID: 36739920.
27. Ly V, Liu L, Cardenas C, Maroongroge S, De B, Basha DE, Court L, Luo X. Parametric delineation uncertainties contouring (PDUC) modeling on CT scans of prostate cancer patients. J Appl Clin Med Phys 24(7):e13970, 2023. e-Pub 2023. PMID: 37078392.
28. De B, Andres G, Bates C, Staren E, Kutscher E, Brooks DJ, Thaker GH, Buscema J, Gin R, Thaker N. Radiation Therapy Expenditures Through the First 8 Performance Periods of the Oncology Care Model at a Statewide Multispecialty Health System. Int J Radiat Oncol Biol Phys 116(3):491-499, 2023. e-Pub 2023. PMID: 36427644.
29. Rooney MK, De B, Corrigan K, Smith GL, Taniguchi C, Minsky BD, Ludmir EB, Koay EJ, Das P, Koong AC, Peacock O, Chang G, You YN, Morris VK, Nogueras-González G, Holliday EB. Patient-reported Bowel Function and Bowel-related Quality of Life After Pelvic Radiation for Rectal Adenocarcinoma: The Impact of Radiation Fractionation and Surgical Resection. Clin Colorectal Cancer 22(2):211-221, 2023. e-Pub 2023. PMID: 36878805.
30. Florez MA, Jaoude JA, Patel RR, Kouzy R, Lin TA, De B, Beck EJ, Taniguchi CM, Minsky BD, Fuller CD, Lee JJ, Kupferman M, Raghav KP, Overman MJ, Thomas CR, Ludmir EB. Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials. JAMA Netw Open 6(5):e2313819, 2023. e-Pub 2023. PMID: 37195664.
31. Dodoo GN, De B, Lee SS, Abi Jaoude J, Vauthey JN, Tzeng CD, Tran Cao HS, Katlowitz KA, Mandel JJ, Beckham TH, Minsky BD, Smith GL, Holliday EB, Koong AC, Das P, Taniguchi CM, Javle M, Koay EJ, Ludmir EB. Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis. Oncologist 28(4):327-332, 2023. e-Pub 2023. PMID: 36715178.
32. Kowalchuk RO, Mullikin TC, Florez M, De BS, Spears GM, Rose PS, Siontis BL, Kim DK, Costello BA, Morris JM, Marion JT, Johnson-Tesch BA, Gao RW, Shiraishi S, Lucido JJ, Trifiletti DM, Olivier KR, Owen D, Stish BJ, Waddle MR, Laack NN, Park SS, Brown PD, Ghia AJ, Merrell KW. Development and validation of a recursive partitioning analysis-based pretreatment decision-making tool identifying ideal candidates for spine stereotactic body radiation therapy. Cancer 129(6):956-965, 2023. e-Pub 2023. PMID: 36571507.
33. Florez MA, De B, Chapman BV, Prayongrat A, Thomas JG, Beckham TH, Wang C, Yeboa DN, Bishop AJ, Briere T, Amini B, Li J, Tatsui CE, Rhines LD, Ghia AJ. Safety and efficacy of salvage conventional re-irradiation following stereotactic radiosurgery for spine metastases. Radiat Oncol J 41(1):12-22, 2023. e-Pub 2023. PMID: 37013414.
34. Kowalchuk R, Mullikin TC, Breen W, Gits HC, Florez M, De B, Harmsen WS, Rose PS, Siontis BL, Costello BA, Morris JM, Lucido JJ, Olivier KR, Stish B, Laack NN, Park S, Owen D, Ghia AJ, Brown PD, Merrell KW. Development and validation of a unifying pre-treatment decision tool for intracranial and extracranial metastasis-directed radiotherapy. Front Oncol 13:1095170, 2023. e-Pub 2023. PMID: 37051531.
35. De B, Florez MA, Ludmir EB, Maor MH, McGovern SL, McAleer MF, Grosshans DR, Chang EL, Mahajan A, Paulino AC. Late Effects of Craniospinal Irradiation Using Electron Spinal Fields for Pediatric Patients With Cancer. Int J Radiat Oncol Biol Phys 115(1):164-173, 2023. e-Pub 2023. PMID: 35716848.
36. Florez MA, De B, Cavazos A, Farooqi A, Beckham TH, Wang C, Yeboa DN, Bishop AJ, McAleer MF, Briere T, Amini B, Li J, Tatsui CE, Rhines LD, Ghia AJ. Safety and Efficacy of Dose-Escalated Radiation Therapy With a Simultaneous Integrated Boost for the Treatment of Spinal Metastases. Pract Radiat Oncol 13(1):e7-e13, 2023. e-Pub 2023. PMID: 36604100.
37. De B, Farooqi AS, Mitchell KG, Ludmir EB, Lewis J, Rinsurongkawong W, Rinsurongkawong V, Lee JJ, Swisher SG, Gibbons DL, Zhang J, Le X, Elamin YY, Gomez DR, Ning MS, Lin SH, Liao Z, Chang JY, Vaporciyan AA, Heymach JV, Antonoff MB, Gandhi SJ. Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival. JCO Precis Oncol 7:e2200540, 2023. e-Pub 2023. PMID: 36716413.
38. Maroongroge S, De B, Woodhouse KD, Bassett RL, Lee P, Bloom ES, Smith GL, Frank SJ, Li J, Perkins G, Das P, Koong AC, Smith BD, Wang C. Physician Perspectives on Telemedicine in Radiation Oncology. Adv Radiat Oncol 8(2):101005, 2023. e-Pub 2023. PMID: 36311822.
39. Brooks ED, Wang X, De B, Verma V, Williamson TD, Hunter R, Mohamed ASR, Ning MS, Zhang X, Chang JY. An algorithm for thoracic re-irradiation using biologically effective dose: a common language on how to treat in a "no-treat zone". Radiat Oncol 17(1):4, 2022. e-Pub 2022. PMID: 34991637.
40. De B, Pasalic D, Barocas DA, Wallis CJD, Huang LC, Zhao Z, Koyama T, Tang C, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Penson DF, Hoffman KE. Patient-reported Outcomes After External Beam Radiotherapy With Low Dose Rate Brachytherapy Boost vs Radical Prostatectomy for Localized Prostate Cancer: Five-year Results From a Prospective Comparative Effectiveness Study. J Urol 208(6):1226-1239, 2022. e-Pub 2022. PMID: 36006050.
41. McGinnis GJ, Holden S, Yu B, Ransom C, Guidarelli C, De B, Diao K, Boyce D, Thomas CR, Winters-Stone K, Raber J. Association of fall rate and functional status by APOE genotype in cancer survivors after exercise intervention. Oncotarget 13(1):1259-1270, 2022. e-Pub 2022. PMID: 36441715.
42. McCulloch MM, Cazoulat G, Svensson S, Gryshkevych S, Rigaud B, Anderson BM, Kirimli E, De B, Mathew RT, Zaid M, Elganainy D, Peterson CB, Balter P, Koay EJ, Brock KK. Leveraging deep learning-based segmentation and contours-driven deformable registration for dose accumulation in abdominal structures. Front Oncol 12:1015608, 2022. e-Pub 2022. PMID: 36408172.
43. Thaker NG, De B, Shah C, Manda S, Royce TJ, Beriwal S. Practical Applications of the Internet of Things in Radiation Oncology. Appl Radiat Oncol, 2022. e-Pub 2022.
44. Sperduto PW, De B, Li J, Carpenter D, Kirkpatrick J, Milligan M, Shih HA, Kutuk T, Kotecha R, Higaki H, Otsuka M, Aoyama H, Bourgoin M, Roberge D, Dajani S, Sachdev S, Gainey J, Buatti JM, Breen W, Brown PD, Ni L, Braunstein S, Gallitto M, Wang TJC, Shanley R, Lou E, Shiao J, Gaspar LE, Tanabe S, Nakano T, An Y, Chiang V, Zeng L, Soliman H, Elhalawani H, Cagney D, Thomas E, Boggs DH, Ahluwalia MS, Mehta MP. Graded Prognostic Assessment (GPA) for Patients With Lung Cancer and Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA Including the Effect of Programmed Death Ligand 1 and Other Prognostic Factors. Int J Radiat Oncol Biol Phys 114(1):60-74, 2022. e-Pub 2022. PMID: 35331827.
45. De B, Corrigan KL, Rooney MK, Ludmir EB, Das P, Smith GL, Taniguchi CM, Minsky BD, Koay EJ, Koong A, Morris VK, Messick CA, You YN, Chang GJ, Westney OL, Nogueras Gonzalez GM, Holliday EB. Patient-Reported Bowel and Urinary Function in Long-Term Survivors of Squamous Cell Carcinoma of the Anus Treated With Definitive Intensity Modulated Radiation Therapy And Concurrent Chemotherapy. Int J Radiat Oncol Biol Phys 114(1):78-88, 2022. e-Pub 2022. PMID: 35589011.
46. Corrigan KL, Rooney MK, De B, Ludmir ED, Das P, Smith GL, Taniguchi C, Minsky BD, Koay EJ, Koong A, Morris VK, Messick CA, Nogueras-Gonzalez G, Holliday EB. Patient-Reported Sexual Function in Long-Term Survivors of Anal Cancer Treated With Definitive Intensity Modulated Radiation Therapy and Concurrent Chemotherapy. Pract Radiat Oncol 12(5):e397-e405, 2022. e-Pub 2022. PMID: 35643295.
47. Corrigan KL, De B, Rooney MK, Ludmir EB, Das P, Smith GL, Taniguchi CM, Minsky BD, Koay EJ, Koong AC, Holliday EB. Patient-Reported Outcomes After Chemoradiation in Patients With Anal Cancer: A Qualitative Analysis. Adv Radiat Oncol 7(4):100986, 2022. e-Pub 2022. PMID: 35662810.
48. De B, Lowenstein LM, Corrigan KL, Andring LM, Kuban DA, Cantor SB, Volk RJ, Hoffman KE. Patients' Preferences for Androgen Deprivation Therapy in the Treatment of Intermediate-Risk Prostate Cancer. MDM Policy Pract 7(2):23814683221137752, 2022. e-Pub 2022. PMID: 36405544.
49. De B, Tran Cao HS, Vauthey JN, Manzar GS, Corrigan KL, Raghav KPS, Lee SS, Tzeng CD, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Javle M, Ludmir EB, Koay EJ. Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States. Cancer 128(13):2529-2539, 2022. e-Pub 2022. PMID: 35417569.
50. De B, Venkatesan AM, Msaouel P, Ghia AJ, Li J, Yeboa DN, Nguyen QN, Bishop AJ, Jonasch E, Shah AY, Campbell MT, Wang J, Zurita-Saavedra AJ, Karam JA, Wood CG, Matin SF, Tannir NM, Tang C. Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation. BJU Int 129(5):610-620, 2022. e-Pub 2022. PMID: 34228889.
51. De B, Fu S, Chen YS, Das P, Ku K, Maroongroge S, Woodhouse KD, Hoffman KE, Nguyen QN, Reed VK, Chen AB, Koong AC, Smith BD, Smith GL. Patient, physician, and policy factors underlying variation in use of telemedicine for radiation oncology cancer care. Cancer Med 11(10):2096-2105, 2022. e-Pub 2022. PMID: 35297210.
52. Manzar GS, De BS, Abana CO, Lee SS, Javle M, Kaseb AO, Vauthey JN, Tran Cao HS, Koong AC, Smith GL, Taniguchi CM, Holliday EB, Das P, Koay EJ, Ludmir EB. Outcomes and Toxicities of Modern Combined Modality Therapy with Atezolizumab Plus Bevacizumab and Radiation Therapy for Hepatocellular Carcinoma. Cancers (Basel) 14(8), 2022. e-Pub 2022. PMID: 35454808.
53. Corrigan KL, Yoder A, De B, Lin L, Jhingran A, Joyner MM, Eifel PJ, Colbert LE, Lu KH, Klopp AH. Long-term survival following definitive radiation therapy for recurrence or oligometastases in gynecological malignancies: A landmark analysis. Gynecol Oncol 164(3):550-557, 2022. e-Pub 2022. PMID: 34974906.
54. Chamseddine I, Kim Y, De B, El Naqa I, Duda DG, Wolfgang J, Pursley J, Paganetti H, Wo J, Hong T, Koay EJ, Grassberger C. Predictive Modeling of Survival and Toxicity in Patients With Hepatocellular Carcinoma After Radiotherapy. JCO Clin Cancer Inform 6(6):e2100169, 2022. e-Pub 2022. PMID: 35192402.
55. De B, Abu-Gheida I, Patel A, Ng SSW, Zaid M, Thunshelle CP, Elganainy D, Corrigan KL, Rooney MK, Javle M, Raghav K, Lee SS, Vauthey JN, Tzeng CD, Tran Cao HS, Ludmir EB, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Koay EJ. Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma. J Pers Med 11(12), 2021. e-Pub 2021. PMID: 34945742.
56. De B, Ludmir EB, Messick CA, Cagley MC, Morris VK, Das P, Minsky BD, Taniguchi CM, Smith GL, Koay EJ, Koong AC, Mohan R, Holliday EB. Prognostic impact of lymphopenia and neutrophil-lymphocyte ratio for patients with anal squamous cell carcinoma. J Gastrointest Oncol 12(5):2412-2422, 2021. e-Pub 2021. PMID: 34790402.
57. Boyce-Fappiano D, Nguyen QN, Chapman BV, Allen PK, Gjyshi O, Pezzi TA, De B, Gomez D, Lin SH, Chang JY, Liao Z, Lee P, Gandhi SJ. Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non-small-cell Lung Cancer. Clin Lung Cancer 22(5):e745-e755, 2021. e-Pub 2021. PMID: 33707003.
58. Yeboa DN, Akinfenwa CA, Nguyen J, Amaya D, de Gracia B, Ning M, Cox V, De B, Smith BD, Lin L, Beddar S, Hoang H, Koong A, Liao Z. Effectively Conducting Oncology Clinical Trials During the COVID-19 Pandemic. Adv Radiat Oncol 6(3):100676, 2021. e-Pub 2021. PMID: 33686374.
59. De B, Ng SP, Liu AY, Avila S, Tao R, Holliday EB, Brownlee Z, Kaseb A, Lee S, Raghav K, Vauthey JN, Minsky BD, Herman JM, Das P, Smith GL, Taniguchi CM, Krishnan S, Crane CH, Grassberger C, Hong TS, Lin SH, Koong AC, Mohan R, Koay EJ. Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy. J Hepatocell Carcinoma 8:57-69, 2021. e-Pub 2021. PMID: 33688489.
60. Medek S, De B, Pater L, Breneman J, Mahajan A, Wolden S, Vatner RE. Practice Patterns Among Radiation Oncologists Treating Pediatric Patients With Proton Craniospinal Irradiation. Pract Radiat Oncol 9(6):441-447, 2019. e-Pub 2019. PMID: 31279941.
61. Gallitto M, Sindhu K, Wasserman I, De B, Gupta V, Miles BA, Genden EM, Posner M, Misiukiewicz K, Bakst RL. Trimodality therapy for oropharyngeal cancer in the TORS era: Is there a cohort that may benefit?. Head Neck 41(9):3009-3022, 2019. e-Pub 2019. PMID: 30997703.
62. De B, Rhome R, Jairam V, Özbek U, Holcombe RF, Buckstein M, Ang C. Gastric adenocarcinoma in young adult patients: patterns of care and survival in the United States. Gastric Cancer 21(6):889-899, 2018. e-Pub 2018. PMID: 29691758.
63. De B, Cahlon O, Sine K, Mah D, Hug EB, Wolden SL. Early Axial Growth Outcomes of Pediatric Patients Receiving Proton Craniospinal Irradiation. J Pediatr Hematol Oncol 40(8):574-579, 2018. e-Pub 2018. PMID: 29889805.
64. De B, Khakoo Y, Souweidane MM, Dunkel IJ, Patel SH, Gilheeney SW, De Braganca KC, Karajannis MA, Wolden SL. Patterns of relapse for children with localized intracranial ependymoma. J Neurooncol 138(2):435-445, 2018. e-Pub 2018. PMID: 29511977.
65. De B, Kinnaman MD, Wexler LH, Kramer K, Wolden SL. Central nervous system relapse of rhabdomyosarcoma. Pediatr Blood Cancer 65(1), 2018. e-Pub 2018. PMID: 28696016.
66. De B, Beal K, De Braganca KC, Souweidane MM, Dunkel IJ, Khakoo Y, Gilheeney SW, DeAngelis LM, Menzel P, Patel SH, Wolden SL. Long-term outcomes of adult medulloblastoma patients treated with radiotherapy. J Neurooncol 136(1):95-104, 2018. e-Pub 2018. PMID: 29019042.
67. De B, Cahlon O, Dunkel IJ, De Braganca KC, Khakoo Y, Gilheeney SW, Souweidane MM, Wolden SL. Reduced-volume radiotherapy for patients with localized intracranial nongerminoma germ cell tumors. J Neurooncol 134(2):349-356, 2017. e-Pub 2017. PMID: 28660318.
68. De B, Rhome R, Doucette J, Buckstein M. Dose escalation of definitive radiation is not associated with improved survival for cervical esophageal cancer: a National Cancer Data Base (NCDB) analysis. Dis Esophagus 30(4):1-10, 2017. e-Pub 2017. PMID: 28375481.
69. Pereira EB, De B, Kolev V, Zakashansky K, Green S, Dottino P, Gupta V. Survey of Current Practice Patterns in the Treatment of Early-Stage Endometrial Cancer. Int J Gynecol Cancer 26(2):341-7, 2016. e-Pub 2016. PMID: 26569061.
70. Liu JT, Kann BH, De B, Buckstein M, Bakst RL, Genden EM, Posner MR, Som PM, Gupta V. Prognostic value of radiographic extracapsular extension in locally advanced head and neck squamous cell cancers. Oral Oncol 52:52-7, 2016. e-Pub 2016. PMID: 26728104.

Other Articles

1. De B, Kinnaman MD, Wexler LH, Kramer K, Wolden SL Erratum: Central Nervous System Relapse of Rhabdomyosarcoma. Pediatr Blood Cancer 64(11), 2017. PMID: 28926690.

Editorials

1. De B, Kuban DA, Tang C. Multidisciplinary clinics in prostate cancer. Oncotarget 12(15):1553-1554, 2021. PMID: 34316333.

Book Chapters

1. De B, Ludmir EB, Koay EJ. Gastric Cancer. In: Pocket Radiation Oncology. 2nd. Wolters Kluwer, 2024.
2. Patel, RR, De, BS, Verma, V. Pulmonary Carcinoid. In: Advances in Radiation Oncology in Lung Cancer, 3rd Ed. B Jeremic. Springer Publishing, 879-904, 2022.
3. De B, Ludmir EB, Koay EJ. Hepatobiliary Cancer. In: Pocket Radiation Oncology. 2nd. Wolters Kluwer.
4. De B, Ludmir EB, Koay EJ. Pancreatic Cancer. In: Pocket Radiation Oncology. 2nd. Wolters Kluwer.

Letters to the Editor

1. De B, Maroongroge S, Smith GL. Letter to the editor regarding "disparities in telemedicine during COVID-19". Cancer Med 12: 1556-1557, 2023.
2. De B, Pasalic D, Barocas DA, Wallis CJD, Huang LC, Zhao Z, Koyama T, Tang C, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Penson DF, Hoffman KE. Reply by Authors. J Urol 208: 1239, 2022.
3. De B, Kaiser KW, Ludmir EB, Yeboa DN, Tang C, Hoffman KE, Liao Z, Koong AC, Smith BD. Radiotherapy clinical trial enrollment during the COVID-19 pandemic. Acta Oncol 60: 312-315, 2021.